<- Go Home
BioGaia AB (publ)
BioGaia AB (publ), a healthcare company, develops, manufactures, markets and sells probiotic products for gut, oral, and immune health in Europe, the Middle East, Africa, the United States, the Asia-Pacific, Australia, and New Zealand. It operates through Pediatrics, Adult Health, and Other segments. The Pediatrics segment offers drops, oral rehydration solutions, and gut health tablets, as well as cultures that are used as an ingredient in infant formula and milk formula. The Adult Health segment provides gut health tablets, bone health tablets and oral health lozenges, as well as cultures, which are used as an ingredient in a licensee’s dairy product. The Other segment provides packaging solutions. It sells its products through distribution partners or through its own distribution channels. BioGaia AB (publ) was incorporated in 1990 and is based in Stockholm, Sweden.
Market Cap
SEK 10.7B
Volume
200.5K
Cash and Equivalents
SEK 622.3M
EBITDA
SEK 440.3M
Tax Rate Collected
N/A
Tax Rate Ratio
N/A
Gross Profit
SEK 1.0B
Profit Margin
72.45%
52 Week High
SEK 139.70
52 Week Low
SEK 93.20
Dividend
6.55%
Price / Book Value
9.23
Price / Earnings
37.24
Price / Tangible Book Value
10.66
Enterprise Value
SEK 10.0B
Enterprise Value / EBITDA
22.35
Operating Income
SEK 423.2M
Return on Equity
21.00%
Return on Assets
15.87
Cash and Short Term Investments
SEK 622.3M
Debt
N/A
Equity
SEK 1.2B
Revenue
SEK 1.4B
Unlevered FCF
SEK 254.0M
Sector
Biotechnology
Category
N/A
Hedge Funds that own this stock
PREMIUM
Upgrade to Yellowbrick Premium to unlock the Professional Funds that own this company (and many other perks).
Upgrade to Yellowbrick PremiumYellowbrick Portfolios that own this stock
PREMIUM
Upgrade to Yellowbrick Premium to unlock the Yellowbrick portfolios that own this company (and many other perks).
Upgrade to Yellowbrick Premium